Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 34 of Foghorn Therapeutics Inc.'s SEC filings and found 5 warrant series, 1 ATM program, 2 shelf registrations, 1 S-1 registration and 2 completed offerings on file for FHTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
SPRBSpruce Biosciences, Inc.
CHRSCoherus Oncology, Inc.
NBPNovaBridge Biosciences
HUMAHumacyte, Inc.
MOLNMolecular Partners AG American Depositary Shares
CDXSCodexis, Inc.
MENSJyong Biotech Ltd. Ordinary Shares
MSLESatellos Bioscience Inc.
CMPXCompass Therapeutics, Inc.
NERVMinerva Neurosciences, Inc.
NMRANeumora Therapeutics, Inc. Common Stock
LENZLENZ Therapeutics, Inc.
PYPDPolyPid Ltd. Ordinary Shares
HURATuHURA Biosciences, Inc.
AVXLAnavex Life Sciences Corp.